11/7/26 The Plausible Mechanism Pathway: A New Evidence Playbook for Rare Disease Development Previous Write Your Own Endpoint Justification Next Leveraging Natural History and RWE for Rare Approvals You Might Also Like One Shot, No Slack: The Clinical Decisions That Make or Break a Rare Disease Program Accelerated Pathways and Global Harmonization Myth-Busting Hybrid & Home-Based Trials: What’s Real, What’s Not and What Scales Patient Input and Digital Health Technologies: A Regulatory Perspective Across the Product Lifecycle Ultra-Rare, Ultra-Lean: Designing for a Viable ROI Under 1,000 Patients
11/7/26 The Plausible Mechanism Pathway: A New Evidence Playbook for Rare Disease Development Previous Write Your Own Endpoint Justification Next Leveraging Natural History and RWE for Rare Approvals You Might Also Like One Shot, No Slack: The Clinical Decisions That Make or Break a Rare Disease Program Accelerated Pathways and Global Harmonization Myth-Busting Hybrid & Home-Based Trials: What’s Real, What’s Not and What Scales Patient Input and Digital Health Technologies: A Regulatory Perspective Across the Product Lifecycle Ultra-Rare, Ultra-Lean: Designing for a Viable ROI Under 1,000 Patients
